Clinical trials
Terminated Phase 2/3 trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Theravance Biopharma | 2 |
| AHEPA University Hospital | 1 |
| Aerovate Therapeutics | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| Incyte Corporation | 1 |
| Invivyd, Inc. | 1 |
| National and Kapodistrian University of Athens | 1 |
| Nektar Therapeutics | 1 |
| Oslo University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 3 |
| Inflammatory Bowel Diseases | 3 |
| Colitis, Ulcerative | 2 |
| Adenocarcinoma of Lung | 1 |
| Adenocarcinoma, Bronchiolo-Alveolar | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Communicable Diseases, Emerging | 1 |
| Coronary Artery Disease | 1 |
| Critical Illness | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.